Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Clinical Investigation

• Publication date

  2012-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI60390PMID 23023708PMCID PMC3534165
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction

  2013cited by this paper
• Mu‐opioid receptor A118G polymorphism in healthy volunteers affects hypothalamic–pituitary–adrenal axis adrenocorticotropic hormone stress response to metyrapone

  2013cited by this paper
• The genetics of the opioid system and specific drug addictions

  2012cited by this paper
• The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review.

  2012cited by this paper
• A common single nucleotide polymorphism A118G of the μ opioid receptor alters its N-glycosylation and protein stability.

  2012cited by this paper
• Medical and nonmedical use of prescription opioids among high school seniors in the United States.

  2012cited by this paper
• A C17T polymorphism in the mu opiate receptor is associated with quantitative measures of drug use in African American women

  2012cited by this paper
• Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats.

  2012cited by this paper
• Treatment-like steady-state methadone in rats interferes with incubation of cocaine sensitization and associated alterations in gene expression.

  2012cited by this paper
• Pharmacogenetics of alcohol, nicotine and drug addiction treatments

  2011cited by this paper
• Regional mRNA expression of the endogenous opioid and dopaminergic systems in brains of C57BL/6J and 129P3/J mice: strain and heroin effects.

  2011cited by this paper
• Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients.

  2011cited by this paper
• Dose escalation and dose preference in extended-access heroin self-administration in Lewis and Fischer rats

  2011cited by this paper
• Involvement of arginine vasopressin and V1b receptor in alcohol drinking in Sardinian alcohol-preferring rats.

  2011cited by this paper
• Nerve growth factor beta polypeptide (NGFB) genetic variability: association with the methadone dose required for effective maintenance treatment

  2011cited by this paper
• Contribution of Cytochrome P450 and ABCB1 Genetic Variability on Methadone Pharmacokinetics, Dose Requirements, and Response

  2011cited by this paper
• Persistent Increase in Hypothalamic Arginine Vasopressin Gene Expression During Protracted Withdrawal from Chronic Escalating-Dose Cocaine in Rodents

  2011cited by this paper
• β-Arrestin2 influences the response to methadone in opioid-dependent patients

  2011cited by this paper
• Single‐nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu‐opioid receptor and may contribute to the genetic risk for addiction

  2010cited by this paper
• Monitoring the Future: National Survey Results on Drug Use, 1975-2007. Volume I, Secondary School Students. NIH Publication No. 08-6418A.

  2010cited by this paper
• Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment

  2010cited by this paper
• Biological pathways and genetic variables involved in pain

  2010cited by this paper
• Forebrain PENK and PDYN gene expression levels in three inbred strains of mice and their relationship to genotype-dependent morphine reward sensitivity

  2010cited by this paper
• Response to Methadone Maintenance Treatment is Associated with the MYOCD and GRM6 Genes

  2010cited by this paper
• A KCNJ6 (Kir3.2, GIRK2) gene polymorphism modulates opioid effects on analgesia and addiction but not on pupil size

  2010cited by this paper
• OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models.

  2010cited by this paper
• A genetic determinant of the striatal dopamine response to alcohol in men

  2010cited by this paper
• Haplotype block structure of the genomic region of the mu opioid receptor gene (OPRM1)

  2010cited by this paper
• Behavioral and Neurochemical Changes Induced by Oxycodone Differ Between Adolescent and Adult Mice

  2009cited by this paper
• Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution

  2009cited by this paper
• Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior

  2009cited by this paper
• Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatment.

  2009cited by this paper
• A Common Human μ-Opioid Receptor Genetic Variant Diminishes the Receptor Signaling Efficacy in Brain Regions Processing the Sensory Information of Pain*

  2009cited by this paper
• Steady-state methadone blocks cocaine seeking and cocaine-induced gene expression alterations in the rat brain.

  2009cited by this paper
• Response to corticotropin-releasing hormone infusion in cocaine-dependent individuals.

  2009cited by this paper
• Mu opioid receptor knockdown in the substantia nigra/ventral tegmental area by synthetic small interfering RNA blocks the rewarding and locomotor effects of heroin.

  2009influential reference
• Involvement of Arginine Vasopressin and V1b Receptor in Heroin Withdrawal and Heroin Seeking Precipitated by Stress and by Heroin

  2008cited by this paper
• Genotype patterns that contribute to increased risk for or protection from developing heroin addiction

  2008cited by this paper
• BDNF variability in opioid addicts and response to methadone treatment: preliminary findings

  2008cited by this paper
• The role of beta-endorphin in the acute motor stimulatory and rewarding actions of cocaine in mice

  2008cited by this paper
• Role of a Functional Human Gene Polymorphism in Stress Responsivity and Addictions

  2008cited by this paper
• ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence.

  2008cited by this paper
• Genetic susceptibility to heroin addiction: a candidate gene association study

  2008cited by this paper
• Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial.

  2008cited by this paper
• Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system

  2008cited by this paper
• Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis.

  2007cited by this paper
• Downregulation of kappa-opioid receptors in basolateral amygdala and septum of rats withdrawn for 14 days from an escalating dose "binge" cocaine administration paradigm.

  2007cited by this paper
• A118g polymorphism in mu opioid receptor gene (oprm1): association with opiate addiction in subjects of Indian origin.

  2007cited by this paper
• Pharmacological properties of bivalent ligands containing butorphan linked to nalbuphine, naltrexone, and naloxone at mu, delta, and kappa opioid receptors.

  2007cited by this paper
• Effect of mu-opioid receptor gene polymorphisms on heroin-induced subjective responses in a Chinese population.

  2007cited by this paper
• The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor

  2007cited by this paper
• Population-specific effects of the Asn40Asp polymorphism at the μ-opioid receptor gene (OPRM1) on HPA-axis activation

  2007cited by this paper
• Stress, dysregulation of drug reward pathways, and the transition to drug dependence.

  2007cited by this paper
• Pharmacological Properties of Bivalent Ligands Containing Butorphan Linked to Nalbuphine, Naltrexone, and Naloxone at μ, δ, and κ Opioid Receptors

  2007cited by this paper
• High Methadone Dose Significantly Reduces Cocaine Use in Methadone Maintenance Treatment (MMT) Patients

  2006cited by this paper
• Mu opioid receptor and orexin/hypocretin mRNA levels in the lateral hypothalamus and striatum are enhanced by morphine withdrawal.

  2006cited by this paper
• Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes.

  2006cited by this paper
• The Mu-Opioid Receptor Polymorphism A118G Predicts Cortisol Responses to Naloxone and Stress

  2006cited by this paper
• Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence.

  2006cited by this paper
• Effects of High-Dose Methadone Maintenance on Cocaine Place Conditioning, Cocaine Self-Administration, and Mu-Opioid Receptor mRNA Expression in the Rat Brain

  2006cited by this paper
• Mechanistic explanation for the unique pharmacologic properties of receptor partial agonists.

  2005cited by this paper
• β-Endorphin-induced locomotor stimulation and reinforcement are associated with an increase in dopamine release in the nucleus accumbens

  2005cited by this paper
• Increased Attributable Risk Related to a Functional μ-Opioid Receptor Gene Polymorphism in Association with Alcohol Dependence in Central Sweden

  2005cited by this paper
• Frequency of recent cocaine and alcohol use affects drug craving and associated responses to stress and drug-related cues.

  2005cited by this paper
• Pharmacogenetics and Human Molecular Genetics of Opiate and Cocaine Addictions and Their Treatments

  2005cited by this paper
• Allelic Expression Imbalance of Human mu Opioid Receptor (OPRM1) Caused by Variant A118G*

  2005cited by this paper
• Endogenous κ-Opioid Receptor Systems Regulate Mesoaccumbal Dopamine Dynamics and Vulnerability to Cocaine

  2005cited by this paper
• Persistent upregulation of μ‐opioid, but not adenosine, receptors in brains of long‐term withdrawn escalating dose “binge” cocaine‐treated rats

  2005cited by this paper
• Neurobiology of craving, conditioned reward and relapse.

  2005cited by this paper
• DHEAS and POMS measures identify cocaine dependence treatment outcome.

  2005cited by this paper
• Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats

  2005cited by this paper
• Amygdalar vasopressin mRNA increases in acute cocaine withdrawal: evidence for opioid receptor modulation.

  2005cited by this paper
• Effect of the endogenous kappa opioid agonist dynorphin A(1-17) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice.

  2004cited by this paper
• Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats

  2004cited by this paper
• Randomized Trial of Buprenorphine for Treatment of Concurrent Opiate and Cocaine Dependence

  2004cited by this paper
• Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden

  2004cited by this paper
• Effect of the endogenous κ opioid agonist dynorphin A(1–17) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice

  2004cited by this paper
• Effect of the A118G polymorphism on binding affinity, potency and agonist‐mediated endocytosis, desensitization, and resensitization of the human mu‐opioid receptor

  2004cited by this paper
• Increased CRH mRNA levels in the rat amygdala during short-term withdrawal from chronic 'binge' cocaine.

  2003cited by this paper
• Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2004.

  2003cited by this paper
• Corticotropin-Releasing Factor Testing Reveals a Dose-Dependent Difference in Methadone Maintained Vs Control Subjects

  2003cited by this paper
• Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.

  2003cited by this paper
• Effect of chronic “binge cocaine” on basal levels and cocaine‐induced increases of dopamine in the caudate putamen and nucleus accumbens of C57BL/6J and 129/J mice

  2003cited by this paper
• Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the μ‐opioid receptor locus (OPRM1)

  2003cited by this paper
• The Mu-Opioid Receptor Gene Polymorphism (A118G) Alters HPA Axis Activation Induced by Opioid Receptor Blockade

  2002cited by this paper
• Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders

  2002cited by this paper
• Pharmacotherapy of addictions

  2002cited by this paper
• Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo–pituitary–adrenocortical axis

  2002cited by this paper
• Altered HPA Axis Responsivity to Metyrapone Testing in Methadone Maintained Former Heroin Addicts with Ongoing Cocaine Addiction

  2001influential reference
• Ethanol consumption and reward are decreased in µ-opiate receptor knockout mice

  2001cited by this paper
• Effect of acute binge cocaine on levels of extracellular dopamine in the caudate putamen and nucleus accumbens in male C57BL/6J and 129/J mice.

  2001cited by this paper
• The D(2) dopamine receptor A(1) allele and opioid dependence: association with heroin use and response to methadone treatment.

  2000cited by this paper
• Stress-induced relapse to heroin and cocaine seeking in rats: a review.

  2000cited by this paper
• Methadone‐Related Opioid Agonist Pharmacotherapy for Heroin Addiction: History, Recent Molecular and Neurochemical Research and Future in Mainstream Medicine

  2000cited by this paper
• The effect of repeated administration of morphine, cocaine and ethanol on mu and delta opioid receptor density in the nucleus accumbens and striatum of the rat.

  1999cited by this paper
• Hypothalamic-pituitary-adrenal activity and pro-opiomelanocortin mRNA levels in the hypothalamus and pituitary of the rat are differentially modulated by acute intermittent morphine with or without water restriction stress.

  1999cited by this paper
• Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.

  1998cited by this paper
• Cocaine Tolerance: Behavioral, Cardiovascular, and Neuroendocrine Function in Men

  1998cited by this paper
• Drug dependence: stress and dysregulation of brain reward pathways.

  1998cited by this paper
• Effects of single and repeated morphine administration on the prodynorphin, proenkephalin and dopamine D2 receptor gene expression in the mouse brain.

  1997cited by this paper

• The Role of Clinical Pharmacogenetics and Opioid Interactions in Pain Management: Current Evidence and Future Perspectives

  2026cites this paper
• Changes in Blood DNA CpG Methylation Levels in Response to Methadone Maintenance Treatment: Epigenome-Wide Longitudinal Study

  2026cites this paper
• Identification of Exercise-Related Signature Genes Potentially Associated with Cocaine Addiction by Integrating Bioinformatics and Mendelian Randomization Analysis

  2025cites this paper
• Honor Norms Predict Lower Support for Opioid Harm Reduction Policies in the U.S.

  2025cites this paper
• Research progress of DNA methylation on the regulation of substance use disorders and the mechanisms

  2025influential citation
• Prophylactic administration of metformin alleviates withdrawal symptoms associated with heroin

  2025cites this paper
• Biochemical Diagnosis in Substance and Non-substance Addiction.

  2025cites this paper
• PET imaging of the opioid system using radioligands: Synthetic approaches and translational applications.

  2025cites this paper
• Psychostimulant and opioid abuse: A perspective from Uruguay.

  2025cites this paper
• Molecular and Environmental Determinants of Addictive Substances

  2024cites this paper
• Opioid use disorder in pediatric populations: considerations for perioperative pain management and precision opioid analgesia

  2024cites this paper
• Impact of OPRM1 (mu-opioid receptor gene) A112G polymorphism on dual oxycodone and cocaine self-administration behavior in a mouse model.

  2024cites this paper
• Solving the Global Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration Therapy

  2024cites this paper
• Cocaine-Induced Remodeling of the Rat Brain Peptidome: Quantitative Mass Spectrometry Reveals Anatomically Specific Patterns of Cocaine-Regulated Peptide Changes.

  2024cites this paper
• Endocannabinoids and related lipids linked to social exclusion in individuals with chronic non-medical prescription opioid use

  2024cites this paper
• Non-canonical signaling initiated by hormone-responsive G protein-coupled receptors from subcellular compartments.

  2024cites this paper
• Comparing clonidine and dexmedetomidine effects in the treatment of opiate withdrawal syndrome in poisoned patients

  2024cites this paper
• Neurogenetics and Epigenetics of Loneliness

  2023cites this paper
• The Neurobiology of Addiction: The Role of Dopamine The Neurobiology of Addiction: The Role of Dopamine

  2023influential citation
• Enrichment Analysis of Biological Pathways and Protein Complexes in the PPI Network Associated with Heroin Use Disorder

  2023cites this paper
• Deficits in consummatory reward relate to severity of cocaine use.

  2023cites this paper
• The Effect of Secondary Sexual Characteristics Outset Time Abnormality on Addiction in Adults: a Mendelian Randomization Study

  2023cites this paper
• AKAP150 from nucleus accumbens dopamine D1 and D2 receptor-expressing medium spiny neurons regulates morphine withdrawal

  2023cites this paper
• The frequency of OPRK1 G36T and OPRM1 A118G opioid receptor gene polymorphisms in heroin-dependent individuals and non-dependent healthy subjects in Turkey

  2023cites this paper
• Evaluation of the Anti-Inflammatory Pain Effect of Ginsenoside-Conjugated O-Carboxymethyl Chitosan Particles

  2023cites this paper
• Topical Cocaine Hydrochloride Nasal Solution: Anesthetic and Surgical Considerations

  2023cites this paper
• Plasma Lysophosphatidic Acid Concentrations in Sex Differences and Psychiatric Comorbidity in Patients with Cocaine Use Disorder

  2023cites this paper
• Neuroplasticity of the extended amygdala in opioid withdrawal and prolonged opioid abstinence

  2023cites this paper
• PCR-RFLP optimisation for OPRM1 rs540825 and rs510769 gene polymorphisms and their allele/genotype frequencies in Turkish population

  2023cites this paper
• Endogenous Opioids and Their Role in Stem Cell Biology and Tissue Rescue

  2022cites this paper
• Blockade of 5-Hydroxytryptamine 2A Receptor Attenuates Precipitation of Naloxone-Induced Withdrawal Symptoms in Opioid-Exposed Mice

  2022cites this paper
• Elevation of Extracellular Glutamate by Blockade of Astrocyte Glutamate Transporters Inhibits Cocaine Reinforcement in Rats via a NMDA-GluN2B Receptor Mechanism

  2022cites this paper
• Establishment of a biomarker of peripheral stress in opioid addicts based on the hypothalamic-pituitary-adrenal axis—The improvement effect of exercise

  2022cites this paper
• Historical Pathways for Opioid Addiction, Withdrawal with Traditional and Alternative Treatment Options with Ketamine, Cannabinoids, and Noribogaine: A Narrative Review.

  2022cites this paper
• Heroin Addiction Induces Axonal Transport Dysfunction in the Brain Detected by In Vivo MRI

  2022cites this paper
• Why haven't we solved the addiction crisis?

  2022cites this paper
• Repeated dosing with cocaine produces strain-dependent effects on responding for conditioned reinforcement in Collaborative Cross mice

  2022cites this paper
• OPRD1 SNPs associated with opioid addiction are cis-eQTLs for the phosphatase and actin regulator 4 gene, PHACTR4, a mediator of cytoskeletal dynamics

  2021cites this paper
• Association between GABA receptor delta subunit gene polymorphisms and heroin addiction.

  2021cites this paper
• Mind-body approaches targeting the psychological aspects of opioid use problems in patients with chronic pain: Evidence and opportunities.

  2021cites this paper
• Neurodevelopmental origins of substance use disorders: Evidence from animal models of early‐life adversity and addiction

  2021cites this paper
• Evidence for Modulation of Substance Use Disorders by the Gut Microbiome: Hidden in Plain Sight

  2021cites this paper
• PRBM_A_292958 2115..2134

  2021cites this paper
• Socio-demographic Characteristics and Drug Abuse Patterns of Combined Amphetamine-Type Stimulants and Opioid Dependence in Malay Male Subjects in Kota Bharu, Kelantan, Malaysia

  2021cites this paper
• Iatrogenic opioid withdrawal syndromes in adults in intensive care units: a narrative review

  2021cites this paper
• Addiction of drugs like Cocaine and Opium - A Review

  2021cites this paper
• The Developmental Origins of Opioid Use Disorder and Its Comorbidities

  2021cites this paper
• A vicious cycle of neuropathological, cognitive and behavioural sequelae of repeated opioid overdose.

  2021cites this paper
• Morinda citrifolia Linn. fruit extract mitigates heroin seeking behavior in mice

  2021influential citation
• GABRB2, a key player in neuropsychiatric disorders and beyond.

  2021cites this paper
• Molecular genetics of cocaine use disorders in humans

  2021cites this paper
• Pain and Management of Pain: A Clinical Review for Craniofacial Surgeons

  2021cites this paper
• The morphine/heroin vaccine decreased the heroin-induced antinociceptive and reinforcing effects in three inbred strains mouse.

  2021cites this paper
• A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing “Precision Behavioral Management”

  2021cites this paper
• The M_3-TT Vaccine Decreases the Antinociceptive Effects of Morphine and Heroin in Mice

  2021cites this paper
• Investigating the CYP2B6 rs3745274 and rs3211371 Polymorphisms in Methadone-Responder and Non-Responder Addicts in Iran

  2021cites this paper
• Use Disorder and Its Comorbidities.

  2021cites this paper
• Neurochemical mechanisms and neurocircuitry underlying the contribution of stress to cocaine seeking

  2021cites this paper
• Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond

  2021cites this paper
• Experimental considerations for the assessment of in vivo and in vitro opioid pharmacology.

  2021cites this paper
• Does a Hypoxic Injury from a Non-fatal Overdose Lead to an Alzheimer Disease?

  2020cites this paper
• Chronic Exposure to Morphine Leads to a Reduced Affective Pain Response in the Presence of Hyperalgesia in an Animal Model of Empathy

  2020cites this paper
• Opioid use disorder

  2020cites this paper
• The Influence of Co-Occurring Substance Use on the Effectiveness of Opiate Treatment Programs According to Intervention Type

  2020cites this paper
• Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy

  2020cites this paper
• The pharmacogenetics of opioid treatment for pain management

  2020influential citation
• Population-specific genetic background for the OPRM1 variant rs1799971 (118A>G): implications for genomic medicine and functional analysis

  2020cites this paper
• Genetic Variation and Sex Mediate Differential Responses to ∆-9-tetrahydrocannabinol among Inbred Mice

  2020cites this paper
• The Association of Co-Occurring Substance Use and the Effectiveness of Opiate Treatment Programs by Intervention Type: A Systematic Review.

  2020cites this paper
• Title : The Exponential-Weight Mean-Variance Model : A novel computational model for the Balloon 1 Analogue Risk Task

  2020cites this paper
• Regulators of G Protein Signaling in Analgesia and Addiction

  2020cites this paper
• Further evidence for association of GAL, GALR1 and NPY1R variants with opioid dependence.

  2020cites this paper
• A functional polymorphism in the ABCB1 transporter predicts pharmacologic response to combination of nortriptyline and morphine in neuropathic pain patients.

  2019cites this paper
• A 3’ UTR SNP rs885863, a cis-eQTL for the circadian gene VIPR2 and lincRNA 689, is associated with opioid addiction

  2019cites this paper
• Modelling Differential Vulnerability to Substance Use Disorder in Rodents: Neurobiological Mechanisms.

  2019cites this paper
• The epigenetic legacy of illicit drugs: developmental exposures and late-life phenotypes

  2019cites this paper
• Genetic and Pharmacologic Studies Towards Prevention of opioid use disorder

  2019cites this paper
• Four single nucleotide polymorphisms in genes involved in neuronal signaling are associated with Opioid Use Disorder in West Virginia.

  2019cites this paper
• Liposome-Encapsulated Morphine Affords a Prolonged Analgesia While Facilitating Extinction of Reward and Aversive Memories

  2019cites this paper
• Newly Emerging Drugs of Abuse.

  2019cites this paper
• Developmental Trajectories of Opioid Use Among Juvenile Offenders: An Epidemiological Examination of Group Characteristics and Criminological Risk Factors

  2019cites this paper
• Role of cytochrome P450 2B6 polymorphisms in unexpected methadone death

  2019cites this paper
• Opioide

  2019cites this paper
• Expression of immediate early genes in brain reward circuitries: Differential regulation by psychostimulant and opioid drugs.

  2019cites this paper
• The Effect of OPRM1 rs648893 Gene Polymorphism on Opioid Addiction in an Iranian population in Zabol: A Case-Control Study

  2019cites this paper
• Non-medical prescription opioid users exhibit dysfunctional physiological stress responses to social rejection.

  2019influential citation
• Methadone maintenance treatment patients with a history of childhood trauma succeed more in a cognitive paradigm that is associated with a negative reward.

  2019cites this paper
• Trace amine-associated receptor gene polymorphism increases drug craving in individuals with methamphetamine dependence

  2019cites this paper
• Comparing Oprm1 Gene Promoter Methylation in the Lymphocytes of Male Rats Addicted to Nicotine, Morphine, Methadone, and Buprenorphine

  2019cites this paper
• Identifying epigenetic targets underlying the effects of prenatal exposure to opioids

  2019cites this paper
• Haplotype-Based Association and In Silico Studies of OPRM1 Gene Variants with Susceptibility to Opioid Dependence Among Addicted Iranians Undergoing Methadone Treatment

  2019cites this paper
• Opioid and stimulant use among a sample of corrections-involved drug users : seeking an understanding of high-risk drug decisions within a system of constraint.

  2019cites this paper
• Structure and dynamics of dynorphin peptide and its receptor.

  2019cites this paper
• The polymorphism of dopamine D2 receptor TaqIA gene is associated with brain response to drug cues in male heroin-dependent individuals during methadone maintenance treatment.

  2019cites this paper
• Actividad eléctrica cerebral de la atención en adolescentes policonsumidores por medio de un equipo de BCI (Brain Control Interface)

  2019cites this paper
• The Opioid Crisis: Biological, Psychological and Sociological Factors in the Etiology and Future Mitigation of Opioid Addiction.

  2019cites this paper
• Influence of dopaminergic system gene polymorphisms on mixed amphetamine-type stimulants and opioid dependence in Malaysian Malays

  2019cites this paper
• Development of a novel computational model for the Balloon Analogue Risk Task: The Exponential-Weight Mean-Variance Model.

  2019cites this paper
• Opioid Use Disorder in Children and Adolescents: Risk Factors, Detection, and Treatment

  2019cites this paper
• Assessing support for safe injection sites among adult constituents in New York.

  2019influential citation